Cover Image
Market Research Report

Infection Prevention & Control - Global Market Outlook (2018-2027)

Published by Stratistics Market Research Consulting Product code 939176
Published Content info 140 Pages
Delivery time: 2-3 business days
Price
Back to Top
Infection Prevention & Control - Global Market Outlook (2018-2027)
Published: May 1, 2020 Content info: 140 Pages
Description

According to Stratistics MRC, the Global Infection Prevention & Control Market is accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period. Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.

Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.

By products & services equipment, the personal protective equipment segment is anticipated to grow at the significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.

On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.

Some of the key players in infection prevention & control market include Danaher Corporation, Johnson & Johnson, Becton, Dickinson, and Company, 3M Company, Baxter International, Ansell Limited, Belimed AG, Aquionics, Bemis Company Incorporated, Abbott, Braun (B.) Melsungen AG, Cantel Medical Corporation, Cardinal Health Incorporated, Covidien, Henkel, Simens, Getinge Group, Hollister, Medtronics, and CCP Industries.

Antimicrobial Drugs Covered:

  • Anti-Fungal Drugs
  • Vaccines
  • Anti-Bacterial Drugs
  • Anti-Viral Drugs

Infection Types Covered:

  • Healthcare Associated Infections
  • Microbial infections

Products & Services Equipment Covered:

  • Infection Prevention Supplies
  • Infection Prevention Equipment

End Users Covered:

  • Drug Usage
  • Equipment Usage

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infection Prevention & Control Market, By Antimicrobial Drugs

  • 5.1 Introduction
  • 5.2 Anti-Fungal Drugs
  • 5.3 Vaccines
  • 5.4 Anti-Bacterial Drugs
  • 5.5 Anti-Viral Drugs

6 Global Infection Prevention & Control Market, By Infection Type

  • 6.1 Introduction
  • 6.2 Healthcare Associated Infections
    • 6.2.1 Community Acquired Infection
      • 6.2.1.1 Community Acquired Pneumonia (CAP)
      • 6.2.1.2 Methicillin Resistant Staphylococcus Aureus (MRSA) Infection
    • 6.2.2 Hospital Acquired Infection
      • 6.2.2.1 Surgical Site Infection
      • 6.2.2.2 Ventilator Associated Pneumonia (VAP) Infection
      • 6.2.2.3 Central Line Associated Bloodstream Infection (CLABSI)
      • 6.2.2.4 Catheter Associated Urinary Tract Infection
  • 6.3 Microbial infections
    • 6.3.1 Fungal Infections
      • 6.3.1.1 Cryptococcus Gatti
      • 6.3.1.2 Aspergillis
      • 6.3.1.3 Pneumocystis Pneumonia (PCP)
      • 6.3.1.4 Dermatophytes
      • 6.3.1.5 Gungal Keratitis
      • 6.3.1.6 Exserohilum
      • 6.3.1.7 Cladosporium
    • 6.3.2 Viral Infections
      • 6.3.2.1 Herpes Simplex Virus
      • 6.3.2.2 Yellow Fever
      • 6.3.2.3 Dengue Viruses
      • 6.3.2.4 Ebola Virus
      • 6.3.2.5 Junin Virus
      • 6.3.2.6 KFD (Kyasanur Forest Virus)
      • 6.3.2.7 Machupo Virus
      • 6.3.2.8 Human Immunodeficiency Virus (HIV)
    • 6.3.3 Clostridium Difficile Infections
      • 6.3.3.1 Escherichia Coli Infections
      • 6.3.3.2 Helicobacter Pylori
      • 6.3.3.3 Salmonella
    • 6.3.4 Exserohilum
    • 6.3.5 Bacterial Infections
      • 6.3.5.1 Mycobacterium Tuberculosis

7 Global Infection Prevention & Control Market, By Products & Services Equipment

  • 7.1 Introduction
  • 7.2 Infection Prevention Supplies
    • 7.2.1 Disinfectants
      • 7.2.1.1 Surgical Disinfectants
      • 7.2.1.2 Environmental Disinfectants
      • 7.2.1.3 Surface Disinfectants
      • 7.2.1.4 Instrument Disinfectants
      • 7.2.1.5 Skin Disinfectants
      • 7.2.1.6 Hand Sanitizers
      • 7.2.1.7 Disinfectants Wipes
    • 7.2.2 Autoclave
      • 7.2.2.1 Horizontal Autoclave
      • 7.2.2.2 Portable Autoclave
      • 7.2.2.3 Vertical Autoclave
    • 7.2.3 Personal Protective Equipment
      • 7.2.3.1 Medical & Laboratory Gloves
      • 7.2.3.1.1 Examination Gloves
      • 7.2.3.1.2 Surgical Gloves
      • 7.2.3.1.3 Laboratory Gloves
      • 7.2.3.2 Surgical Masks & Respirators
      • 7.2.3.3 Surgical Foot Covers
      • 7.2.3.4 Surgical Drapes
      • 7.2.3.4.1 Nonwoven Drapes
      • 7.2.3.4.2 Plastic Drapes
      • 7.2.3.4.3 Woven Drapes
      • 7.2.3.5 Surgical Gowns
      • 7.2.3.6 Patient Gowns
      • 7.2.3.7 Surgical & Staff Face Masks
      • 7.2.3.8 Other Personal Protective Equipment
      • 7.2.3.8.1 Disposable Staff Apparel
      • 7.2.3.8.2 Disposable Towels & Bedding
    • 7.2.4 Safety-Enhanced Medical Devices
      • 7.2.4.1 Safety-Enhanced Syringes
      • 7.2.4.1.1 Prefillable Syringes
      • 7.2.4.1.2 Safety-Enhanced Clinical Syringes
      • 7.2.4.2 Safety-Enhanced Catheters
      • 7.2.4.2.1 IV Catheters
      • 7.2.4.2.2 Urinary Catheters
      • 7.2.4.3 Safety-Enhanced Blood Collection Tubes
    • 7.2.5 Sterilization Supplies
      • 7.2.5.1 Sterile Containers
      • 7.2.5.2 Sterilization Wrap
      • 7.2.5.3 Sterilization Indicators
    • 7.2.6 Medical Waste Disposal Supplies
      • 7.2.6.1 Medical Waste Disposal Containers
      • 7.2.6.2 Medical Waste Disposal Accessories
  • 7.3 Infection Prevention Equipment
    • 7.3.1 Sterilization Equipment
      • 7.3.1.1 Sterilization Technologies
      • 7.3.1.1.1 Filtration Sterilization
      • 7.3.1.1.2 Radiation Sterilization
      • 7.3.1.1.3 Low Temperature Sterilization
      • 7.3.1.1.3.1 In-House Steam Sterilization
      • 7.3.1.1.3.2 Ethylene Oxide (EO) Sterilization
      • 7.3.1.1.3.3 Gamma and e-Beam Sterilization
      • 7.3.1.1.4 Wet/Stream Sterilization
      • 7.3.1.1.5 Dry Heat Sterilization
      • 7.3.1.1.6 Contract Sterilization Services
    • 7.3.2 Washing/Disinfecting Equipment
    • 7.3.3 Endoscope Reprocessors
    • 7.3.4 Other Infection Prevention Equipment
      • 7.3.4.1 Infectious Waste Receptacles
      • 7.3.4.2 Infectious Waste Processing Units

8 Global Infection Prevention & Control Market, By End User

  • 8.1 Introduction
  • 8.2 Drug Usage
    • 8.2.1 Individuals & Patients
    • 8.2.2 Nursing & Senior care Centers
  • 8.3 Equipment Usage
    • 8.3.1 Medical Laboratories
    • 8.3.2 Manufacturing Units
      • 8.3.2.1 Pharmaceuticals
      • 8.3.2.2 Medical Devices
      • 8.3.2.3 Food & Beverages Industry
    • 8.3.3 Hospitals & Clinics
    • 8.3.4 Life Science Industry

9 Global Infection Prevention & Control Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Danaher Corporation
  • 11.2 Johnson & Johnson
  • 11.3 Becton, Dickinson, and Company
  • 11.4 3M Company
  • 11.5 Baxter International
  • 11.6 Ansell Limited
  • 11.7 Belimed AG
  • 11.8 Aquionics
  • 11.9 Bemis Company Incorporated
  • 11.10 Abbott
  • 11.11 Braun (B.) Melsungen AG
  • 11.12 Cantel Medical Corporation
  • 11.13 Cardinal Health Incorporated
  • 11.14 Covidien
  • 11.15 Henkel
  • 11.16 Simens
  • 11.17 Getinge Group
  • 11.18 Hollister
  • 11.19 Medtronics
  • 11.20 CCP Industries

List of Tables

  • Table 1 Global Infection Prevention & Control Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Infection Prevention & Control Market Outlook, By Antimicrobial Drugs (2017-2027) ($MN)
  • Table 3 Global Infection Prevention & Control Market Outlook, By Anti-Fungal Drugs (2017-2027) ($MN)
  • Table 4 Global Infection Prevention & Control Market Outlook, By Vaccines (2017-2027) ($MN)
  • Table 5 Global Infection Prevention & Control Market Outlook, By Anti-Bacterial Drugs (2017-2027) ($MN)
  • Table 6 Global Infection Prevention & Control Market Outlook, By Anti-Viral Drugs (2017-2027) ($MN)
  • Table 7 Global Infection Prevention & Control Market Outlook, By Infection Type (2017-2027) ($MN)
  • Table 8 Global Infection Prevention & Control Market Outlook, By Healthcare Associated Infections (2017-2027) ($MN)
  • Table 9 Global Infection Prevention & Control Market Outlook, By Community Acquired Infection (2017-2027) ($MN)
  • Table 10 Global Infection Prevention & Control Market Outlook, By Hospital Acquired Infection (2017-2027) ($MN)
  • Table 11 Global Infection Prevention & Control Market Outlook, By Microbial infections (2017-2027) ($MN)
  • Table 12 Global Infection Prevention & Control Market Outlook, By Fungal Infections (2017-2027) ($MN)
  • Table 13 Global Infection Prevention & Control Market Outlook, By Viral Infections (2017-2027) ($MN)
  • Table 14 Global Infection Prevention & Control Market Outlook, By Clostridium Difficile Infections (2017-2027) ($MN)
  • Table 15 Global Infection Prevention & Control Market Outlook, By Exserohilum (2017-2027) ($MN)
  • Table 16 Global Infection Prevention & Control Market Outlook, By Bacterial Infections (2017-2027) ($MN)
  • Table 17 Global Infection Prevention & Control Market Outlook, By Products & Services Equipment (2017-2027) ($MN)
  • Table 18 Global Infection Prevention & Control Market Outlook, By Infection Prevention Supplies (2017-2027) ($MN)
  • Table 19 Global Infection Prevention & Control Market Outlook, By Disinfectants (2017-2027) ($MN)
  • Table 20 Global Infection Prevention & Control Market Outlook, By Autoclave (2017-2027) ($MN)
  • Table 21 Global Infection Prevention & Control Market Outlook, By Protective Apparel & Textiles (2017-2027) ($MN)
  • Table 22 Global Infection Prevention & Control Market Outlook, By Safety-Enhanced Medical Devices (2017-2027) ($MN)
  • Table 23 Global Infection Prevention & Control Market Outlook, By Sterilization Supplies (2017-2027) ($MN)
  • Table 24 Global Infection Prevention & Control Market Outlook, By Medical Waste Disposal Supplies (2017-2027) ($MN)
  • Table 25 Global Infection Prevention & Control Market Outlook, By Infection Prevention Equipment (2017-2027) ($MN)
  • Table 26 Global Infection Prevention & Control Market Outlook, By Sterilization Equipment (2017-2027) ($MN)
  • Table 27 Global Infection Prevention & Control Market Outlook, By Washing/Disinfecting Equipment (2017-2027) ($MN)
  • Table 28 Global Infection Prevention & Control Market Outlook, By Endoscope Reprocessors (2017-2027) ($MN)
  • Table 29 Global Infection Prevention & Control Market Outlook, By Other Infection Prevention Equipment (2017-2027) ($MN)
  • Table 30 Global Infection Prevention & Control Market Outlook, By End User (2017-2027) ($MN)
  • Table 31 Global Infection Prevention & Control Market Outlook, By Drug Usage (2017-2027) ($MN)
  • Table 32 Global Infection Prevention & Control Market Outlook, By Individuals & Patients (2017-2027) ($MN)
  • Table 33 Global Infection Prevention & Control Market Outlook, By Nursing & Senior care Centers (2017-2027) ($MN)
  • Table 34 Global Infection Prevention & Control Market Outlook, By Equipment Usage (2017-2027) ($MN)
  • Table 35 Global Infection Prevention & Control Market Outlook, By Medical Laboratories (2017-2027) ($MN)
  • Table 36 Global Infection Prevention & Control Market Outlook, By Manufacturing Units (2017-2027) ($MN)
  • Table 37 Global Infection Prevention & Control Market Outlook, By Hospitals & Clinics (2017-2027) ($MN)
  • Table 38 Global Infection Prevention & Control Market Outlook, By Life Science Industry (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Back to Top